CLINICAL ROLE -
Trends in Medication Utilization and the Cost of Treatment for Gout
With new drugs in the pipeline and the impact of updated FDA drug safety policies on colchicine, gout may no longer be inexpensive to treat.
Read More
Palbociclib Combination Therapy Improves Outcomes for HR-positive, HER2-positive Metastatic Breast Cancer
Systemic Immune-Inflammation Index Associated With Increased Risk of Depressive Symptoms
Children With Autism Are More Likely to Be Diagnosed with Leukemia, Study Finds
Posdinemab Receives FDA Fast Track Designation for Treatment of Alzheimer Disease